Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 9, 2018.
Article Versions
- previous version (April 18, 2018 - 16:57).
- You are viewing the most recent version of this article.
Copyright & Usage
© PDA, Inc. 2018
Author Information
- Kyle Zingaro1,*,
- David Shaw2,*,
- Jerry Carson3,
- Anke Mayer-Bartschmid4,
- Christian Bender4,
- Christina Alves5,
- Duncan Mcvey6,
- Nan-Xin Qian7,
- Qingxiang Wei8,
- Michael W. Laird2,
- Yuan Zhu9,
- Robyn Emmins10,
- John A. Follit11,
- Alison Porter12,
- Andrew J. Racher12,
- Sarah Milne12,
- Ivan Carubelli12,
- Zhimei Du13,
- Ankita Khatri13,
- Marilyne Failly14,
- Hervé Broly15,
- Frank Lee16,
- Matthew Reeser16,
- Jared Spidel16,
- Karin Anderson17,
- Christine Demaria18,
- Jennifer Di-Carlo19,
- John Gill20,
- Amie Lundquist20,
- Sampath R. Kumar21 and
- Tony Gill22
- 1Alexion Pharmaceuticals, Inc., New Haven, CT, USA;
- 2Genentech, Inc., South San Francisco, CA, USA;
- 3AbbVie Bioresearch Center, Worcester, MA, USA;
- 4Bayer AG, Pharmaceuticals, Research and Development, Cell and Protein Sciences, Wuppertal, Germany;
- 5Biogen, Cell Culture Development, Cambridge, MA, USA;
- 6Bristol-Myers Squibb, Pennington, NJ, USA;
- 7Bristol-Myers Squibb, Devens, MA, USA;
- 8Celgene Corporation, Summit West, Summit, NJ, USA;
- 9GSK, King of Prussia, PA, USA;
- 10GSK, Stevenage, UK;
- 11ImmunoGen, Inc., Waltham, USA;
- 12Lonza Biologics plc, Slough, UK;
- 13Merck & Co., Inc., Kenilworth, NJ, USA;
- 14Merck Biodevelopment, Martillac, France;
- 15Merck Serono S.A., Fenil-sur-Corsier, Switzerland;
- 16Morphotek, Inc., Exton, PA, USA;
- 17Pfizer BioTherapeutics Pharmaceutical Sciences, Andover, MA, USA;
- 18Sanofi Biopharmaceutics Development, Framingham, MA USA;
- 19Sanofi Biopharmaceutics Development, Vitry-sur-Seine, France;
- 20Shire, Lexington, MA, USA;
- 21Takeda Pharmaceuticals International Co., Cambridge, MA, USA; and
- 22BioPhorum Development Group, Sheffield, UK
- ↵* Corresponding Authors: Kyle Zingaro, Alexion Pharmaceuticals, Inc., 100 College Street, New Haven, CT 06510, USA. Telephone: +1 475 230 2273; e-mail: kyle.zingaro{at}gmail.com; David Shaw, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Telephone: +1 650 467 7336; e-mail: david.shaw{at}gene.com
